Back to top

Company News For Nov 27, 2018

Read MoreHide Full Article
  • Zafgen, Inc.’s (ZFGN - Free Report) shares plummeted 40.6% after the FDA put U.S. trials of the company’s experimental diabetes drug on hold, citing safety concerns
  • Shares of Cleveland-Cliffs Inc. (CLF - Free Report) declined 1.3% after it announced a new $200 million stock buyback program
  • Aetna. Inc.’s shares gained 2.3% after CVS Health Corporation (CVS - Free Report) received the final regulatory nod to acquire the company
  • Shares of GW Pharmaceuticals plc (GWPH - Free Report) increased 2.9% after the company announced positive top-line results for its cannabinoid-based childhood-onset epilepsy treatment, Epidiolex


More from Zacks Corporate Summary

You May Like